Company Analysis Novartis
1. Summary
Advantages
- Dividends (3.67%) are higher than the sector average (1.31%).
- The stock's return over the last year (15.41%) is higher than the sector average (-33.71%).
- The company's current efficiency (ROE=31.82%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Price (109.95 $) is higher than fair price (87.71 $)
- Current debt level 24.76% has increased over 5 years from 22.98%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 17:51 Drugmakers raised prices by 6.6% on average early this year
2.3. Market efficiency
| Novartis | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.4% | -1.2% | 1.2% |
| 90 days | 11.8% | -30% | -5.2% |
| 1 year | 15.4% | -33.7% | 9.5% |
NVS vs Sector: Novartis has outperformed the "Healthcare" sector by 49.12% over the past year.
NVS vs Market: Novartis has outperformed the market by 5.9% over the past year.
Stable price: NVS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NVS with weekly volatility of 0.2963% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (109.95 $) is higher than the fair price (87.71 $).
Price is higher than fair: The current price (109.95 $) is 20.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (13.91) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (13.91) is lower than that of the market as a whole (73.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.42) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (4.42) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.43) is higher than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (4.43) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (11.89) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (11.89) is lower than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 16.79% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (16.79%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (31.82%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (31.82%) is higher than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (14.86%) is higher than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (14.86%) is higher than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (27.51%) is higher than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (27.51%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.67% is higher than the average for the sector '1.31%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.67% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 3.67% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (48.86%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
